Back to Journals » OncoTargets and Therapy » Volume 16

Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report

Total article views   HTML views PDF downloads Totals
4,125 Dovepress* 3,079+ 81 3,160
PubMed Central* 1,046 247 1,293
Totals 4,125 328 4,453
*Since 21 February 2023
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 2 3

View citations on PubMed Central and Google Scholar